"Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.
| Descriptor ID |
D014612
|
| MeSH Number(s) |
D20.215.894
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Vaccines".
This graph shows the total number of publications written about "Vaccines" by people in this website by year, and whether "Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 7 | 0 | 7 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 1 | 3 |
| 2021 | 2 | 0 | 2 |
| 2022 | 9 | 0 | 9 |
| 2023 | 10 | 0 | 10 |
| 2024 | 2 | 0 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccines" by people in Profiles.
-
How Can We Accelerate Maternal Vaccination Globally? Pediatr Infect Dis J. 2025 Feb 01; 44(2S):S11-S12.
-
Vaccine stock-outs: A preventable health facility obstacle contributing to missed vaccinations in South African children. Vaccine. 2025 Jan 25; 45:126583.
-
Obstetric and neonatal outcomes in South Africa. Vaccine. 2024 Feb 27; 42(6):1352-1362.
-
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date. Paediatr Drugs. 2024 Mar; 26(2):101-112.
-
Combinatorial multimer staining and spectral flow cytometry facilitate quantification and characterization of polysaccharide-specific B cell immunity. Commun Biol. 2023 10 28; 6(1):1095.
-
Risks of Adverse Outcomes for Hospitalized COVID-19 Patients during the Four Waves in Brazil According to SARS-CoV-2 Variants, Age Group, and Vaccine Status. Viruses. 2023 09 26; 15(10).
-
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19. Nat Immunol. 2023 07; 24(7):1161-1172.
-
COVID-19 as a catalyst for vaccine manufacturing: A South African experience. Cell Host Microbe. 2023 06 14; 31(6):839-842.
-
Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa. Lancet Infect Dis. 2023 08; 23(8):e288-e300.
-
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines. Front Immunol. 2023; 14:1130539.